ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesChapter 12: Diseases of the skin and subcutaneous tissueL64

L64

Non-billable

Androgenic alopecia

Chapter 12:Diseases of the skin and subcutaneous tissue

BILLABLE STATUSNo
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/06/2025

Code Description

ICD-10 L64 is a used to indicate a diagnosis of androgenic alopecia.

Key Diagnostic Point:

Androgenic alopecia, commonly known as male or female pattern baldness, is a hereditary condition characterized by progressive hair thinning and loss. It primarily affects the scalp, where hair follicles shrink over time due to the influence of androgens, particularly dihydrotestosterone (DHT). Clinically, it presents as a receding hairline in men and diffuse thinning over the crown in women. The condition typically begins in adulthood, with varying degrees of severity and onset age. The progression can be gradual, leading to significant psychological distress and social implications for affected individuals. Diagnosis is primarily clinical, based on patient history and physical examination, although dermatoscopy can assist in confirming the diagnosis by revealing miniaturized hair follicles. In some cases, a scalp biopsy may be warranted to rule out other causes of hair loss. Understanding the anatomy of hair follicles and the hormonal pathways involved is crucial for effective management and treatment planning.

Code Complexity Analysis

Complexity Rating: Medium

Medium Complexity

Complexity Factors

  • Diagnostic complexity: Moderate, as it requires differentiation from other types of alopecia.
  • Treatment complexity: Moderate, with various treatment options including topical minoxidil and oral finasteride.
  • Documentation requirements: Requires detailed patient history and treatment response documentation.
  • Coding specificity: Moderate, as L64 specifically addresses androgenic alopecia but may require additional codes for associated conditions.

Audit Risk Factors

  • Common coding errors: Misclassification of alopecia types.
  • Documentation gaps: Incomplete patient history or treatment documentation.
  • Billing challenges: Denials due to lack of evidence for medical necessity of treatments.

Specialty Focus

Medical Specialties

Dermatology

Documentation Requirements

Standard ICD-10-CM documentation requirements apply

Common Clinical Scenarios

Various clinical presentations within this specialty area

Billing Considerations

Follow specialty-specific billing guidelines

Endocrinology

Documentation Requirements

Standard ICD-10-CM documentation requirements apply

Common Clinical Scenarios

Various clinical presentations within this specialty area

Billing Considerations

Follow specialty-specific billing guidelines

Related CPT Codes

CPT Code

Clinical Scenario

Documentation Requirements

CPT Code

Clinical Scenario

Documentation Requirements

CPT Code

Clinical Scenario

Documentation Requirements

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

Androgenic alopecia affects a significant portion of the population, with estimates suggesting that up to 50% of men and women experience some degree of hair loss by age 50. This condition can lead to decreased quality of life and psychological distress, impacting mental health and social interactions. Understanding the epidemiology of androgenic alopecia is essential for healthcare providers to address the needs of affected individuals and improve overall population health outcomes.

ICD-9 vs ICD-10

Androgenic alopecia affects a significant portion of the population, with estimates suggesting that up to 50% of men and women experience some degree of hair loss by age 50. This condition can lead to decreased quality of life and psychological distress, impacting mental health and social interactions. Understanding the epidemiology of androgenic alopecia is essential for healthcare providers to address the needs of affected individuals and improve overall population health outcomes.

Reimbursement & Billing Impact

reimbursement, as some insurers may only cover treatments deemed medically necessary rather than cosmetic. Regular audits of coding practices can help mitigate risks associated with billing errors.

Resources

Clinical References

  • •
    ICD-10 Official Guidelines for L00-L99
  • •
    Clinical Documentation Requirements

Coding & Billing References

  • •
    ICD-10 Official Guidelines for L00-L99
  • •
    Clinical Documentation Requirements

Frequently Asked Questions

What specific conditions are covered by L64?

L64 specifically covers androgenic alopecia, which includes male pattern baldness (L64.0) and female pattern hair loss (L64.1). It is characterized by a progressive thinning of hair due to genetic predisposition and hormonal influences.

When should L64 be used instead of related codes?

L64 should be used when the diagnosis is specifically androgenic alopecia. If the hair loss is due to other causes, such as alopecia areata or telogen effluvium, different codes should be selected.

What documentation supports L64?

Documentation should include a thorough patient history detailing the onset and pattern of hair loss, physical examination findings, and any treatments attempted. Photographic evidence may also be beneficial.